Ocera Therapeutics fka OCRX

[king oil]

Monteverde & Associates PC Announces An Investigation Of Ocera Therapeutics, Inc. - OCRX

NEW YORK, Nov. 2, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Ocera Therapeutics, Inc. ("Ocera" or the "Company") (NasdaqCM: OCRX) relating to the sale of the Company to Mallinckrodt PLC (NYSE: MNK). As a result of the merger Ocera shareholders are only anticipated to receive $1.52 in cash plus a contingent value right to receive one or more payments of up to $2.58 per share.

The investigation focuses on whether Ocera and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company's stockholders by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017, an award given to less than 2.5% of attorneys in a particular field.

If you own common stock in Ocera and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [e-mail] or by telephone at [phone].

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[e-mail]
Tel: [phone]


https://www.morningstar.com/news/pr-news-wire/PRNews_20171102DC34189/shareholder-alert-monteverde-associates-pc-announces-an-investigation-of-ocera-therapeutics-inc-ocrx.html